HCV

Because new HCV infections are usually asymptomatic, few people are diagnosed when the infection is recent. In those people who go on to develop chronic HCV infection, the infection is also often undiagnosed because it remains asymptomatic until decades after infection when symptoms develop secondary to serious liver damage. The most common strategy, it is testing for anti-HCV antibodies with a serological test identifies people who have been infected with the virus. In this way, Peptidepharma company had identified several peptide antigens from (Core, envelope proteins such as E1 and E2/NS1) and six non-structural (NS2, NS3, NS4a, NS4b, NS5a y NS5b) that can be used in ELISA, rapid test, western-blot methods for sera recognition with more than 90% specificity and sensitivity and not cross reactivity against others organisms that cause other respiratory infection have been observed.